Search - tctmd.com

Displaying 261 - 280 of 392

Sort: Relevancy | Date

Presentation TVT 2022

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Presenter: Tamim M. Nazif

June 08, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Presenter: Geoffrey Kunz

June 08, 2022

Presentation TVT 2022

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

Presenter: Saif Anwaruddin

June 08, 2022

Presentation TVT 2022

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2022

AR Home Run/Home Tomorrow

Presenter: Pratik Dalal

June 08, 2022

Presentation TVT 2022

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Presenter: Mark Bieniarz

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Presenter: Nicolas Van Mieghem

June 08, 2022

Presentation TVT 2022

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Presenter: Andrei Pop

June 08, 2022

Presentation TVT 2022

Pre-Procedure segment; efficiently working-up your TAVR patient

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Presentation TVT 2022

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Presenter: Andrea Scotti

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Presenter: Tsuyoshi Kaneko

June 08, 2022

Advertisement

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

AR Home Run/Home Tomorrow

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Pre-Procedure segment; efficiently working-up your TAVR patient

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Transcatheter Aortic Valve Replacement With the Self-Expanding ACURATE neo2: Hemodynamic Performance and Clinical Outcomes

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Surgical Explants After TAVI Failures: Prohibitive or an Acquired Taste

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content